This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y.Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis. Cancer 112: 1058-1065, No. 5, 1 Mar 2008
Rights and permissions
About this article
Cite this article
Finasteride financially viable for prostate cancer prevention?. Pharmacoecon. Outcomes News 550, 6 (2008). https://doi.org/10.2165/00151234-200805500-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805500-00012